The method described in this work is able to select molecules active against MAC.
Introduction
Mycobacterium avium complex (MAC) is a group of opportunistic bacterial pathogens related to Mycobacterium tuberculosis that are found almost everywhere in our environment, including food, water and soil. The emergence of natural resistant MAC clinical isolates in immunodeficient patients, 1 and the spread of multidrug-resistant M. tuberculosis in several world areas, emphasize the need for new antimycobacterial drugs.
Alternative antimicrobial treatment has been employed in the therapy of infections caused by these organisms. Agents such as fluoroquinolones, novel macrolides or rifamycin derivates, have been introduced for the control of multidrug-resistant or latent tuberculosis infections, 2 but experience shows that the use of high-cost treatment in developing countries is limited, and, on the other hand, an accelerated increase in resistance is observed. Thus, more extensive investigations are needed. Many other new drugs are being evaluated to obtain efficient treatments and entirely novel classes of compounds such as oxazolidinones, nitroimidazoles, riminophenazines, ketolides, nitroimidazopyrans, pyridones, lipophilic analogues of isoniazid, 3 thiazine derivates 4 and carboxamidrazone analogues, 5 showing antimycobacterial activity are being developed. The identification of novel targets requires the characterization of mycobacterium-specific biochemical pathways, but the rational design of new antimycobacterial agents is complex and many metabolic processes are unknown.
Most of the drug design methods currently available demand a previous knowledge of the mechanism of action involved. However, extramechanistic approaches are increasingly being used to design new drugs. Concretely, molecular topology 6 has proved a useful formalism to find quantitative structure-activity relationships (QSAR). One of the most interesting advantages of molecular topology is the straightforward calculation of the topological descriptors. In this method, each structure is assimilated to a hydrogen-depleted graph where the atoms are represented by vertices and the bonds by edges; the connectivity between atoms is represented in topological matrices, which can be either distance or adjacency. Mathematical manipulation of such matrices provides different sets of numbers called topological indices (TI), [7] [8] [9] descriptive structural levels. 6, 10 If well-chosen, these topological descriptors can be used for the selection and design of new analgesics, 11 bronchodilators, 12 antihistamines, 13 antivirals, 14 antibacterials, 15 antifungals, 16 etc., many of which can be considered as lead drugs. In a recent paper, we have developed a study of prediction of quinolone activity against M. avium by molecular topology and virtual computational screening. 17 The aim of this study was to develop new QSAR models, based on TI, statistical linear discriminant analysis (LDA) and multilinear regression analysis (MLRA), in order to select new drugs and to predict their in vitro activity, expressed as MIC 90 (lowest concentration of an antimicrobial that inhibits 90% of the different strains of bacteria), against M. avium complex.
Materials and methods

Statistical treatment
The search for new compounds showing antimycobacterial activity was carried out using the following steps: Structural descriptors. A group of compounds with known anti-MAC activity was selected from several sources. 17 6 and differences and quotients, m D t and m C t , between them; 20 topological charge indices, G m and J m , 25 and 10 other discrete invariants. 24 Linear discriminant analysis (LDA). The objective of LDA is to find linear functions able to discriminate between two or more categories. In our case, two groups of compounds were considered for analysis. The first included 22 anti-MAC drugs, and 35 presumably inactive compounds made up the second. These compounds constituted the training set. LDA was carried out with the BMDP package, module 7M (W. J. Dixon, BMDP Statistical Software, University of California, Berkeley, CA, USA). The selection of the descriptors was based on the FisherSnedecor F parameter. Stepwise, the variable that adds the most to the separation of the groups is entered into (or the variable that adds the least is removed from) the discriminant function (DF). The classification criterion was the maximal posterior classification probability. It is basically proportional to the Mahalanobis distance from the data points to the centroid. This is the point that represents the means for all variables in the multivariate space defined by the group. The quality of the DF is evaluated by the Wilks parameter (λ) and the percentage of correct classifications into each group (discriminant ability). The independent variables in this study were TI, and the discrimination property was the presence or absence of anti-MAC activity.
The validation of the selected DF was carried out both by an internal leave-n-out test, in which the program randomly chooses and pulls out a number of compounds and uses them to evaluate the DFs obtained with the remainder, and by an external test set of non-previously used data. A randomness test, in which the classification variable was randomly reassigned and discriminant functions with the same number of variables as DF were obtained, was also carried out in order to compare these equations with DF and detect possible chance effects.
The equation obtained by LDA must be able to predict the existence of the antimycobacterial activity for a given structure and, consequently, must be useful to select new candidate drugs. In order to choose intervals of values derived from this equation in which the active compounds showed their optimal values, a pharmacological activity distribution diagram (PDD), was used. 26 This is a histogram-like plot of the calculated DF in which expectancies appear on the ordinate axis. For an arbitrary interval of values of a given function, the expectancy of activity is E a =a/(i+100), where a is the percentage of active compounds in the interval and i is the corresponding percentage of inactive compounds within the same interval. The expectancy of inactivity is defined likewise as E i =i/(a+100). This representation provides good visualization of the regions of minimum overlap and helps to select regions in which the probability of finding active compounds is optimal. Multilinear regression analysis, MLRA. The property, MIC 90 against MAC expressed in mg/L and µmol/L, as well as their respective logarithms, were correlated versus TI in order to select the best regression equation.
The MLRA was carried out with the 9R module of the BMDP program, which estimates regression equations for the best subsets of predictor variables and provides detailed residual analysis by using the Furnival-Wilson algorithm. 27 Equations with minimal Mallows C p parameter 28 were initially chosen.
The stability of the equation selected was evaluated through a crossvalidation by the leave-one-out algorithm. 29 To do this, one compound of the set is extracted, and the model is recalculated using the remaining N-1 compounds as the training set. The property is then predicted for the removed element. This process is repeated for all the compounds of the set so obtaining a prediction for each one. This procedure also aids in the detection of outlying points.
In order to examine the possible existence of fortuitous regressions, the randomization test was adopted in this paper. 30 Thus, the values of the property of each compound are randomly permuted and linearly correlated with the aforementioned descriptors. This process is repeated as many times as compounds are in the set. The usual way to represent the results of a randomization test is by plotting the correlation coefficients versus predicted ones, r 2 (squared multiple correlation) and r 2 cv (squared multiple correlation by cross-validation) respectively. Virtual screening. The equations obtained and the corresponding intervals constitute a model for the filtering of databases. If a molecule has its output values from the equations within the thresholds, it is selected as potentially active. Otherwise it is discarded. In this work, a homemade database of approx. 20 000 compounds was used, extracted from the Merck Index and the Sigma-Aldrich databases.
Microbiological study
Thirty-two M. avium complex isolates from respiratory and non-respiratory clinical samples from the Hospital Clínico Universitario de Valencia, Spain, were used in this study. All isolates were identified by DNA hybridization probes (Accuprobe, Gen Probe Inc., San Diego, CA, USA). Susceptibility to conventional antimycobacterial drugs (azithromycin, ciprofloxacin, clarithromycin, clofazimine, ethambutol, moxifloxacin and rifabutin) and the selected drugs was carried out by a microdilution method. 31 The organisms were grown in modified Middlebrook 7H9 broth supplemented with 10% OADC (oleic acid/albumin/dextrose/catalase) enrichment (Difco Laboratories) for 7 days at 37°C. The inoculum size was obtained by dilution of a culture suspension in 7H9 broth to yield an absorbance equivalent to that of a 0.5 McFarland Standard for M. avium complex isolates.
Antimicrobial susceptibility tests were carried out in 96-well microplates using serial two-fold microdilution in 7H9 broth. Initial drug dilutions were prepared in deionized water or, if not soluble, dimethyl sulphoxide. Subsequent two-fold dilutions were carried out in 150 µL of modified 7H9 broth in the microplates to provide a final test range of 128 to 0.125 mg/L. Ten microlitres of a suspension of mycobacteria were added to the wells. Plates were covered with Parafilm 'M' (Laboratory Film, American National Can), and incubated for 5 days at 37°C. Starting at 5 days of incubation, 20 µL of resazurin (Sigma 2127) with a concen-tration of 250 mg/L was added to the wells, and the microplates were reincubated at 37°C for an additional period of 48 h. MIC 50 (lowest concentration of an antimicrobial that inhibits 50% of the different strains of bacteria) and MIC 90 values were determined as the lowest concentrations of the compounds yielding no visible changes from blue to pink. 32
Results and discussion
Linear discrimination analysis
The compounds included in the LDA are a structurally heterogeneous set of drugs (ranging from simple structures, such as benzoic acid, up to much more complex structures, such as aminoglycosides). is the contribution of G 1 v , which is the only one that it is positive and can be considered as the total molecular electronic density. Its maximum value corresponds to the viomycins, neomycin B and rifampicin that also exhibit the greater DF value. Conversely isoniazid and tuberin, having the lowest values of G 1 v also present low DF, even negative for isoniazid. Charge transfers through heteroatoms separated by three bonds are limiting in this equation. So, small molecules such as azaserine and carnitine are inactive. Table 1 shows the results of the classification for each one of the compounds included in the LDA. As can be seen in Table 1 , the linear equation gave good results since most compounds are classified with a When the probability of activity or probability of inactivity is >0.60, the compound is classified as active (+) or inactive (-), respectively. For any other case, the compound is non-classified (NC).
Compound DF 934 -a posterior probability of over 80%. Under this framework, the error percentage in the active set was about 14%, whereas in the inactive it was about 6%. The validation on an internal set is illustrated in Table 2 . Five runs were carried out. A number of compounds, ranging from 8 to 16, were randomly extracted from a training to a test set. Wilks λ values for each equation are displayed. The percentages of correct classification for training and test sets, for active and inactive compounds, are shown. The number of compounds classified as active (+) or inactive ). E, expectancy of activity or inactivity; solid line, active group; dashed line, inactive group. As can be seen, the optimal DF range to find active compounds is 0 < DF < 4. (-) appears parenthetical, where (a/b) = number of (+) compounds/ number of (-) compounds. Average values are also shown, as well as the reference equation performance. The results for the training and test groups are within the same range. The average percentage of success obtained with the training group was 84% for active (+) and 97% for inactive (-) . For the test, it was 72% and 92%, respectively. The results were similar to the ones obtained with DF equation, which points out the validity of Equation 1.
The LDA results on the external validation test are shown in Table 3 . For the active set, we found a misclassified compound, namely imipenem. The same occurs in the opposite group, where chloropal and benorylate are misclassified. Table 4 shows the results obtained in the randomness test for DF. Five runs were carried out with the 22 active compounds and the 35 inactive compounds from the original sets. A number of randomly chosen compounds, between five and eight, were changed category in each run and new equations with four variables were obtained. As can be seen in Table 4 , the new equations obtained showed greater λ and a lower classification ability, which indicates that Equation 1 models a true structural pattern. Figure 1 shows the PDD obtained from DF. As can be seen, the optimal DF range to find active compounds must be redefined between 0 and 4. Compounds lying between -0.5 and 0 were considered non-classified (+/-) because many active compounds can be found in this interval, although the proportion of inactive compounds is much greater.
Multilinear regression analysis
After carrying out correlations with the MIC 90 values (in mg/L and µmol/L) and with their logarithms versus TI (Table 5) , the best linear regression equation obtained corresponded to MIC 90 expressed in mg/L ( Table 5 ). The activity expressed in micromolar concentration was not so well correlated. This can be explained because some of the descriptors used (connectivity indices, G charge indices and discrete invariants) are obtained by summations of fragment contributions. Thus, they are not absolutely independent from the molecular mass. The use of molar magnitudes introduces a redundant factor. In relation to the logarithmic correlations, they usually give better results with variables that span several magnitude orders, which is not the case.
The selected equation and its statistical parameters were: Table 7 . Application of the MAC model to the database a Molecules classified as '+/-' pass through -0.5 < DF < 4 and 0 < P < 20.
Compound DF Classification DF interval 0 < DF < 4 P value Classification P interval 0 < P < 20 2 , those corresponding to G 5 and 2 C. The first is related to electronic density and is partially compensated by the G 4 v term that is of the same type. Fluoroquinolones give great values for the balance between these terms. Likewise, the term with 2 C, related to electronic transfers through two bonds, is partially compensated by 4 C c in the case of aminoglycosides, rifabutin and macrolides because these are the only members of the training set that display carbons bonded to four different non-hydrogen atoms.
The observed and calculated P for each compound and the P obtained in the cross-validation study are shown in Table 6 . The prediction success of P was very satisfactory if we consider that we are working with a non-logarithmic property, and it is also significant that it can distinguish between low and high values of P.
The results of the cross-validation analysis (leave-one-out) are outlined in column 4 of Table 6 .
The results obtained from the stability and randomness analysis for P (Equation 2) are shown in Figure 2 . Figure 2 It is considered that good drug candidates should display a calculated P (MIC 90 ) lower than 20 mg/L, in accordance with that proposed by Heifets in 1996. 33 This author considers that compounds with MIC 90 values between 4 and 16 mg/L should be considered moderately active drugs, and those with values lower than 4 mg/L should be considered as active drugs. Furthermore, some conventional drugs such as cycloserine and capreomycin, present an interval of susceptibility in vitro between 5 and 20 mg/L. 
Topological mathematical model and virtual screening
The model to filter potential active molecules for database searches against MAC is constituted by the equations DF (Equation 1) and P (Equation 2) with their corresponding intervals: 0 < DF < 4 and 0 < P < 20.
After building a home-made database, a virtual screening with the MAC model to select potentially active molecules was carried out. Table 7 shows the molecules found, their values for DF (Equation 1) and P (Equation 2) and the classification results.
Those molecules classified as '+/-' pass through -0.5 < DF < 4 and 0 < P < 20 because, as can be seen in PDD (Figure 1) , in the interval -0.5 to 0, active compounds could be found.
Microbiological study
The results of the susceptibility test against MAC for conventional drugs are shown in Table 8 , and the experimental results for the new compounds are illustrated in Table 9 . The two tables show the MIC range (variation between sensitive and non-sensitive strains) in column 2, the MIC 50 in column 3 and the MIC 90 in column 4.
According to the criterion suggested by Heifets 33 to interpret MICs against M. avium complex of conventional drugs, the set of isolates included in our study represents no specific resistance profile and the method used here is reproducible and comparable with the standardized proportion method ( Table 8) .
As can be seen in Table 9 , all of the selected compounds classified as '+/-' by the model were inactive against MAC except ribavirin. Those classified as '+' exhibited antimycobacterial activity against the tested strains, with MIC 50 ranging from 4 to 64 mg/L (Table 9) . These results confirm the validity of the model.
Particularly active were benzalkonium chloride, paromomycin, pentamidine and trifluoperazine with MIC 50 values ≤16 mg/L. Benzalkonium chloride is a quaternary ammonium compound (QAC) with activity over bacterial membranes and activity against Gram-positive bacteria such as Staphylococcus aureus isolates. In an experimental disinfection assay, QACs are mycobacteriostatic agents even at low concentrations. 34 Our results indicate the possibility of increasing the susceptibility of mycobacteria to other agents for the treatment of cutaneous processes. Paromomycin is an oligosaccharidetype antibiotic with demonstrated antibacterial 35 and antiamoebic activity, but it is not used as a primary antimycobacterial drug. Pentamidine, a dibenzamidine derivate, is an antimicrobial agent with activity against protozoa and Pneumocystis carinii; it inhibits aerobic glycolysis. Trifluoperazine is a phenotiazine employed in the treatment of psychosis, which has demonstrated inhibition of in vitro growth of multidrug-resistant M. tuberculosis 36 by a calmodulin antagonist mechanism.
Less active but still showing significant inhibition results, were aflatoxin B1 (MIC 50 = 32 mg/L), reserpine and ribavirin (MIC 50 = 64 mg/L for both). Reserpine, an antihypertensive drug, demonstrated an inhibitory effect in Gram-positives by an efflux inhibition mechanism. A probable drug efflux protein has been characterized in M. tuberculosis and other mycobacteria. 37 Aflatoxin B1, a secondary fungal metabolite, and ribavirin, the first synthetic non-interferoninducing broad-spectrum antiviral nucleoside, are two molecules with limited applications as antibacterial drugs as a result of important toxicological problems.
The structures of the selected compounds are presented in Figure 3 . The wide structural diversity of the selected compounds is noteworthy, since they could eventually be considered as new leads in this field.
Concluding remarks
The most active compounds were benzalkonium chloride, trifluoperazine, paromomycin and pentamidine, with MIC 90 values of 4, 8, 16 and 32 mg/L, respectively. Their respective predicted values were 17, 8, 7 and 15 mg/L.
The great structural heterogeneity of the selected compounds must be noted although some of them, paromomycin, reserpine and trifluoperazine, show described antimycobacterial activity. For these compounds, we have checked that our theoretical calculations of activity are comparable to those obtained in vitro and to those reported by other groups. On the other hand, trifluoperazine had been described as an inhibitor of the in vitro growth of multidrug-resistant M. tuberculosis. However, no reference of activity against MAC appears in the literature.
The fact that the method described in this work is able to select molecules that have been identified by other means enhances the validity of our approach. These results confirm other previously published work, so indicating the usefulness of molecular topology as a potent tool to identify new drugs, especially new leads. It also overcomes the need for previous knowledge on the drug mechanism of action.
